These data suggest that the differences in NK cell subpopulations between AML and control groups are not isolated events but are rather present in most AML patients as they might actually reflect a process in which the immune system is such modulated in order to push the NK differentiation and lead to the persistence of the highly cytotoxic CD57+ cells. Here, B3GAT1 is linked to acute myeloid leukemia.